News
-
2024.9.5 Glac Biotech Brings Hope to Guangfu Elementary — A Story of Warmth in the Hills of Nantou
2025/08/08 -
2024.5.31 Glac Biotech’s Probiotic Business Set to Break NT$500 Million in Revenue — A Story of Growth, Strategy, and Gl
2025/08/08 -
2024.5.10 Glac Biotech Becomes First Taiwanese Probiotic Manufacturer to Earn U.S. GRAS Certification
2025/08/07 -
2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation
2025/08/07 -
2024.1.26 Glac Biotech’s Year-End Celebration — Revenue Soars Over 30% as Leadership Champions the Future
2025/08/08 -
2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations
2025/08/08 -
2024.4.2 Glac Biotech’s Probiotic Strains F-1 & CP-9 — The Secret Engine Powering Global OEM Success
2025/08/07 -
2023.10.26 Totipro® PE0401 Steals the Spotlight at SSW — Glac Biotech’s Postbiotic Innovation Draws Global Attention
2025/08/08 -
2023.9.28 Glac Biotech’s Totipro® PE0401 Makes History — First Postbiotic Ever to Win a NutraIngredients Award
2025/09/17